Recce Pharmaceuticals
Sydney
About Recce Pharmaceuticals
Recce Pharmaceuticals is a world leader in synthetic polymer-antibiotics. The Company is developing a new class of broad spectrum antibiotics targeting superbugs.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $37.7M
- Funding stage: IPO
- Last round: Post-IPO Equity (Apr 2025)
- Ticker: asx:RCE
- Website: recce.com.au
- Phone: +61 (2) 8075 4585
Industries & Categories
Biotechnology, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/recce-pharmaceuticals-146594 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.